Effect of KRN7000 on induced graft-vs-host disease.

Morecki, Shoshana; Panigrahi, Soumya; Pizov, Galina; Yacovlev, Elena; Gelfand, Yael; Eizik, Osnat; Slavin, Shimon

Morecki, Shoshana; Panigrahi, Soumya; Pizov, Galina; Yacovlev, Elena; Gelfand, Yael; Eizik, Osnat; Slavin, Shimon.

Affiliation

Morecki S; Department of Bone Marrow Transplantation & Cancer Immunotherapy, Cell Therapy & Transplantation Research Center, Hadassah University Hospital, Jerusalem, Israel. morecki@hadassah.org.il

Exp Hematol ; 32(7): 630-7, 2004 Jul.

Article in En | MEDLINE | ID: mdl-15246159

Subject(s)

Galactosylceramides/therapeutic use; Graft vs Host Disease/drug therapy; Lymphocyte Transfusion/methods; Adjuvants, Immunologic/therapeutic use; Animals; Crosses, Genetic; Female; Flow Cytometry; Graft vs Host Disease/immunology; Graft vs Host Disease/mortality; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Time Factors; Transplantation Conditioning; Transplantation, Homologous/immunology; Whole-Body Irradiation

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Lymphocyte Transfusion / Galactosylceramides / Graft vs Host Disease Type of study: Prognostic_studies Limits: Animals Language: En Journal: Exp Hematol Year: 2004 Document type: Article Affiliation country: Israel Country of publication: Netherlands

Search on Google

Add to My VHL

XML

PubMed Links